MILVERDENE LIMITED

Company Registration Number:
01305803 (England and Wales)

Unaudited abridged accounts for the year ended 31 May 2023

Period of accounts

Start date: 01 June 2022

End date: 31 May 2023

MILVERDENE LIMITED

Contents of the Financial Statements

for the Period Ended 31 May 2023

Balance sheet
Notes

MILVERDENE LIMITED

Balance sheet

As at 31 May 2023


Notes

2023

2022


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 3,418,300 3,341,299
Total fixed assets: 3,418,300 3,341,299
Current assets
Stocks: 768,247 311,646
Debtors: 4 1,968,384 1,975,724
Cash at bank and in hand: 5,584,030 4,334,452
Investments: 5 123,738 89,543
Total current assets: 8,444,399 6,711,365
Creditors: amounts falling due within one year: 6 (1,172,833) (1,071,647)
Net current assets (liabilities): 7,271,566 5,639,718
Total assets less current liabilities: 10,689,866 8,981,017
Total net assets (liabilities): 10,689,866 8,981,017
Capital and reserves
Called up share capital: 2 2
Revaluation reserve:7390,622390,622
Profit and loss account: 10,299,242 8,590,393
Shareholders funds: 10,689,866 8,981,017

The notes form part of these financial statements

MILVERDENE LIMITED

Balance sheet statements

For the year ending 31 May 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 30 January 2024
and signed on behalf of the board by:

Name: Philip James Wagstaff
Status: Director

The notes form part of these financial statements

MILVERDENE LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

MILVERDENE LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2023

2. Employees

2023 2022
Average number of employees during the period 28 28

MILVERDENE LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2023

3. Tangible Assets

Total
Cost £
At 01 June 2022 3,634,318
Additions 176,933
Disposals (37,224)
At 31 May 2023 3,774,027
Depreciation
At 01 June 2022 293,019
Charge for year 68,555
On disposals (5,847)
At 31 May 2023 355,727
Net book value
At 31 May 2023 3,418,300
At 31 May 2022 3,341,299

MILVERDENE LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2023

4. Debtors

2023 2022
££
Debtors due after more than one year: 1,504,300 1,448,800

MILVERDENE LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2023

5. Current investments

Listed Investments

MILVERDENE LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2023

6. Creditors: amounts falling due within one year note

Trade Creditors - 247006Corporation tax - 458531Other Taxes. - 52219Vat. - 330347Other Creditors - 19736Director's Loan. - 5543Shareholders Loan - 59451 -------------- 1172833 ========

MILVERDENE LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2023

7. Revaluation reserve

2023
£
Balance at 01 June 2022 390,622
Surplus or deficit after revaluation 0
Balance at 31 May 2023 390,622

MILVERDENE LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2023

8. Related party transactions

Name of the related party:
Relationship:
common director
Description of the Transaction: Loans to associated companies
£
Balance at 01 June 2022 1,448,800
Balance at 31 May 2023 1,504,300

The director Mr P J Wagstaff is a director of both the associated companies